Peptivoice

IGF-1 LR3 reconstitution calculator

long arginine 3 IGF-1

IGF-1 LR3 is an engineered insulin-like growth factor built to resist binding proteins, extending its activity. It sits at the hard end of the gray market: genuine anabolic biology, genuine acute hypoglycemia risk, unavoidable oncological questions (IGF-1 signaling feeds cell growth indiscriminately), and zero legitimate route.

Regulatory status (August 2026). Not FDA-approved; research chemical with no compounding pathway. Prohibited at all times in sport (WADA S2). Carries a real acute risk unusual among gray-market peptides: hypoglycemia.
Reconstitution · IGF-1 LR3math only - no dosing advice
0102030405060708090100U-100 · UNITS

Enter vial size, water volume, and the dose your provider gave you.

This tool converts the numbers you enter (dose ÷ concentration = volume). It never suggests a dose. The FDA has documented hospitalizations caused by mg / ml / unit conversion errors with vial-and-syringe products - if the readout surprises you, stop and verify with your prescriber or pharmacist.

Questions people actually search

Why do IGF-1 LR3 vials contain only 1 mg?

Because amounts discussed are tiny - tens of mcg. A 1 mg vial with 2 ml of water gives 0.5 mg/ml; 50 mcg = 0.1 ml = 10 units. The small magnitudes make arithmetic errors proportionally more dangerous here than with any other peptide on this site.

What is the hypoglycemia risk?

IGF-1 shares insulin's ancestry and lowers blood glucose - the approved pharmaceutical version (mecasermin, for rare growth disorders) carries hypoglycemia warnings on its label. Gray-market use without glucose awareness reproduces that risk with none of the monitoring.

Is IGF-1 LR3 detectable in doping tests?

Yes - growth factors are WADA S2 substances screened by modern anti-doping labs, and IGF-1 analogs have produced sanctions. For any tested athlete this compound is a career-ending risk.

Read the full reconstitution guide →